Analysts are positive on these five top "strong buy" dividend stocks for this year. They make sense for growth and income ...

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...

Biotech and pharmaceutical company Pfizer has announced plans to reorganise its activities in Kenya amid emerging market dynamics.

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

There has been a shakeup in markets since Donald Trump’s election, and investors have been positioning their portfolios to ...

New Activin R-based medications can emerge as perfect solutions for balancing weight loss and muscle building, making a ...

EY—the professional services firm originally known as Ernst & Young—reports the dollar value of biopharma M&A deals nosedived ...

Vaccines like Pfizer-BioNTech required ultra-low temperatures, which was a logistical challenge. Suddenly, companies had to ...

Canadian Prime Minister Justin Trudeau has suggested that President-elect Donald Trump’s remarks about Canada becoming ...

The global biologics contract development and manufacturing organization (cdmo) market size is estimated to grow by USD 16.32 ...

Both Lilly and Pfizer claim their programmes tap into the increased willingness of patients to use telehealth services since they became normalised during the COVID-19 pandemic, whilst opening up ...

The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price controls for the selected drugs will become effective in 2027.